{"id":"W2998828459","doi":"10.1093/ecco-jcc/jjz203.110","title":"DOP71 Efficacy, safety, and tolerability of ustekinumab in paediatric patients with moderately to severely active Crohn’s disease: Results from, UniStar, a phase 1 study","year":2020,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Tolerability; Ustekinumab; Crohn's disease; Internal medicine; Gastroenterology; Adverse effect; Placebo; Tumor necrosis factor alpha; Infliximab; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001476089,0.0007063773,0.001826163,0.000270952,0.0002273421,0.0007736219,0.0004374207,0.0007279529,0.002524366],"category_scores_gemma":[0.001099314,0.0003683083,0.0009567674,0.0004030517,0.0006434219,0.0005704454,0.0003433918,0.00164434,0.0006410158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005299041,"about_ca_system_score_gemma":0.000945488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003810924,"about_ca_topic_score_gemma":0.001368347,"domain_scores_codex":[0.9993667,0.0003492749,0.00005226984,0.00007659413,0.0000751535,0.00008000569],"domain_scores_gemma":[0.9991912,0.0001914655,0.000259278,0.00005199886,0.00006542775,0.0002405765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6970394,0.02989484,0.02267725,0.003294018,0.002004324,0.0006881801,0.0006254095,0.001847962,0.08134874,0.0002301264,0.004263524,0.1560862],"study_design_scores_gemma":[0.3540551,0.5717302,0.05925991,0.0001613244,0.001213952,0.001169421,0.0001509385,0.0008049668,0.006209547,0.0001103334,0.005082818,0.00005155475],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912294,0.006060636,0.0002049683,0.0001672759,0.00004539607,0.0005853012,0.0007613242,0.00004524165,0.0009004053],"genre_scores_gemma":[0.9923028,0.003513641,0.001009107,0.0003645493,0.00009569875,0.0005541633,0.001340373,0.00001586638,0.0008037444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002524366,"threshold_uncertainty_score":0.008444905,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009045823325461746,"score_gpt":0.2439393737207454,"score_spread":0.2348935503952836,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}